Brand Name Drugs Rise in Price; Generics Go Down
Tuesday, June 08, 2010
While Congress struggled to adopt national healthcare reform throughout last year and into the beginning of 2010, pharmaceutical manufacturers continued to hike the price of name-brand medications.
An analysis of drug prices by the AARP Public Policy Institute revealed that brand name drugs rose more than 9% from March 2009 to March 2010—despite the fact that inflation was close to zero for consumer goods.
Some individual medications rocketed even higher during the one-year period under review. Flomax, for example, leaped 27.6% in cost.
Although brand name pharmaceuticals went up in price, generic drugs fell by an average of 9%.
-David Wallechinsky
Brand Name and Specialty Drug Prices Continue to Climb (Rx Watchdog Report, AARP) (pdf)
- Top Stories
- Unusual News
- Where is the Money Going?
- Controversies
- U.S. and the World
- Appointments and Resignations
- Latest News
- Bashar al-Assad—The Fall of a Rabid AntiSemite
- Trump Announces He Will Switch Support from Russia to Ukraine
- Americans are Unhappy with the Direction of the Country…What’s New?
- Can Biden Murder Trump and Get Away With it?
- Electoral Advice for the Democratic and Republican Parties
Comments